AHT – 424B3 March 31, 2026 In SEC https://www.sec.gov/Archives/edgar/data/1232582/000123258226000079/0001232582-26-000079-index.htm #AHT Press Release: Sanofi’s Rezurock approved in the EU to treat chronic graft-vs-host disease JPMorganChase Launches American Dream Initiative to Expand Local Economic Opportunity